Nextcure, INC Form 4 insider transactions

Director Anne Elizabeth Borgman acquired stock options in NextCure, Inc. on June 20, 2024.

Kevin G. Shaw, Sr VP and General Counsel of NextCure, Inc., reports the acquisition of 93,900 stock options.

NextCure CEO Michael Richman was granted employee stock options to purchase 244,400 shares of common stock on March 29, 2024.

Han Myint, Chief Medical Officer of NextCure, Inc., acquired 93,900 employee stock options on March 29, 2024, according to a Form 4 filing with the SEC.

Timothy Mayer, Chief Operating Officer of NextCure, Inc., reports the acquisition of employee stock options.

Sol Langermann, Chief Scientific Officer of NextCure, Inc., was granted employee stock options on March 29, 2024.

Sourav Kundu, Sr VP, Dev. & Mfg. at NextCure, Inc., acquired 52,900 employee stock options on March 29, 2024.

NextCure's CFO, Steven P. Cobourn, reported the acquisition of 93,900 employee stock options on March 29, 2024.